Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Comparison of Antiarrhythmic and Myocardial Protective Effect Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft

NCT01688648 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01688648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01688648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Comparison of Antiarrhythmic and Myocardial Protective Effect Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2012
Completion date
February 28, 2013
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, blood electrolyte balance, coronary artery bypass graft, dexmedetomidine, lidocaine, myocardial injury, unstable angina